Janssen HL - Search Results

1

Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.

Veldt BJ, van der Vliet HJ, von Blomberg BM, van Vlierberghe H, Gerken G, Nishi N, Hayashi K, Scheper RJ, de Knegt RJ, van den Eertwegh AJ, Janssen HL, van Nieuwkerk CM. Veldt BJ, et al. Among authors: janssen hl. J Hepatol. 2007 Sep;47(3):356-65. doi: 10.1016/j.jhep.2007.04.018. Epub 2007 Jun 6. J Hepatol. 2007. PMID: 17599630 Clinical Trial.

2

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Janssen HL, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, Meyer zum Buschenfelde KH, Chamuleau RA, Jansen PL, Reesink HW, et al. Janssen HL, et al. Gut. 1992 Aug;33(8):1094-8. doi: 10.1136/gut.33.8.1094. Gut. 1992. PMID: 1398234 Free PMC article.

3

Suicide associated with alfa-interferon therapy for chronic viral hepatitis.

Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Janssen HL, et al. J Hepatol. 1994 Aug;21(2):241-3. doi: 10.1016/s0168-8278(05)80402-7. J Hepatol. 1994. PMID: 7989716

4

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.

Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Janssen HL, et al. Hepatology. 1993 Mar;17(3):383-8. Hepatology. 1993. PMID: 8444411 Clinical Trial.

5

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

Janssen HL, Schalm SW, Berk L, de Man RA, Heijtink RA. Janssen HL, et al. J Hepatol. 1993;17 Suppl 3:S47-51. doi: 10.1016/s0168-8278(05)80423-4. J Hepatol. 1993. PMID: 8509639

6

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

7

Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.

Heijtink RA, Janssen HL, Hop WC, Osterhaus AD, Schalm SW. Heijtink RA, et al. Among authors: janssen hl. J Viral Hepat. 2000 Sep;7(5):382-6. doi: 10.1046/j.1365-2893.2000.00246.x. J Viral Hepat. 2000. PMID: 10971827 Clinical Trial.

8

Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication.

Heijtink RA, Janssen HL, Hop WC, Osterhaus AD, Schalm SW. Heijtink RA, et al. Among authors: janssen hl. J Med Virol. 2001 Mar;63(3):217-9. J Med Virol. 2001. PMID: 11170060 Clinical Trial.

9

The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome.

Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, Janssen HL. Tang TJ, et al. Among authors: janssen hl. J Hepatol. 2001 Sep;35(3):338-43. doi: 10.1016/s0168-8278(01)00131-3. J Hepatol. 2001. PMID: 11592594

10

Extrahepatic portal vein thrombosis: aetiology and determinants of survival.

Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B. Janssen HL, et al. Gut. 2001 Nov;49(5):720-4. doi: 10.1136/gut.49.5.720. Gut. 2001. PMID: 11600478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters